Oxycodone and Acetaminophen Tablets
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
18,003 recalls, newest first
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Defective Container: Recall is due to breaking and shattering of ampules upon opening
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Firm is recalling 46 lots of various products because of a lack of sterility assurance.
Marketed without an Approved NDA/ANDA: FDA analysis found this product to contain undeclared Tadalafil, an FDA approved drug for the treatment of erectile dysfunction
Lack of Assurance of Sterility